Patent 8198320 was granted and assigned to Taipei Medical University on June, 2012 by the United States Patent and Trademark Office.
The present invention relates to a method for controlling blood glucose level and a method for the prophylaxis or treatment of diabetes mellitus and/or its complications. The present invention further relates to an anti-diabetic formulation for controlling blood glucose level and/or for the prophylaxis or treatment of diabetes mellitus and/or its complications.